7621 - 7630 of 8824 Results
Title
Year
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 21
-
OPENTitle: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 74End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502Citation Count: 11
-
RESTRICTEDTitle: Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common MarmosetJournal Name: NeurosciencePublisher: Elsevier BVVol: 480Issue #:Start Page: 143End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.11.009Citation Count: 12
-
RESTRICTEDTitle: Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic NeuronsJournal Name: NeurosciencePublisher: Elsevier BVVol: 506Issue #:Start Page: 114End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2022.10.011Citation Count: 2
-
RESTRICTEDTitle: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachJournal Name: NeuropeptidesPublisher: Elsevier BVVol: 96Issue #:Start Page: 102283End Page: 102283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283Citation Count: 11
-
OPENTitle: A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid BindingJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 433Issue #: 24Start Page: 167323End Page: 167323Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2021.167323Citation Count: 15
-
RESTRICTEDTitle: The Importance of Cross-Disciplinary Research: A Commentary on “Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease”Journal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 969End Page: 971Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.01.010Citation Count: 0
-
RESTRICTEDTitle: Optimal Treatment of Depression and Anxiety in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 6Start Page: 530End Page: 540Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.02.037Citation Count: 65
-
RESTRICTEDTitle: Are hedge funds' charitable donations strategic?Journal Name: Journal of Corporate FinancePublisher: Elsevier BVVol: 66Issue #:Start Page: 101842End Page: 101842Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jcorpfin.2020.101842Citation Count: 15
-
OPENTitle: Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesiclesJournal Name: CytotherapyPublisher: Elsevier BVVol: 23Issue #: 5Start Page: 373End Page: 380Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jcyt.2021.01.001Best OA location URL: http://hdl.handle.net/11380/1251814Citation Count: 223